Breaking News

Ranbaxy to Deploy Instem’s Preclinical Software

May 9, 2014

Will automate lab processes at R&D headquarters in India

Ranbaxy Laboratories has purchased Instem’s Provantis preclinical software suite to automate lab processes at its R&D headquarters in Gurgaon, India. Provantis modules to be deployed include Inlife, Pathology, Tables & Statistics, Clinical Pathology, Protocol & Report Assembly, which will replace in-house developed applications. 
 
Neil Donaldson, Instem’s vice president of global sales, Europe & Asia, said, “We are delighted to welcome Ranbaxy as our newest client in the Asia Pacific region and look forward to a long and successful partnership. Instem recognizes the increasingly important role that Indian organizations play in the global pharmaceutical market and we are committed to supporting the future growth and development of the Indian R&D community.”
  • When Quality Meets Confidence

    When Quality Meets Confidence

    Dr. Fadia AlKhalil, Vice President of Global Business Development for Laboratory Services, SGS ||November 9, 2016
    A look at global account management for R&D outsourcing

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus